Inflammation, Lipid (Per)oxidation, and Redox Regulation

炎症 活性氧 脂质体 细胞生物学 生物 氧化应激 氧化磷酸化 线粒体 转录因子 脂类学 生物化学 脂质氧化 化学 抗氧化剂 免疫学 基因
作者
Irundika H.K. Dias,Ivana Milic,Christian Heiß,Opeyemi Stella Ademowo,Maria Cristina Polidori,Andrew Devitt,Helen R. Griffiths
出处
期刊:Antioxidants & Redox Signaling [Mary Ann Liebert, Inc.]
卷期号:33 (3): 166-190 被引量:54
标识
DOI:10.1089/ars.2020.8022
摘要

Significance: Inflammation increases during the aging process. It is linked to mitochondrial dysfunction and increased reactive oxygen species (ROS) production. Mitochondrial macromolecules are critical targets of oxidative damage; they contribute to respiratory uncoupling with increased ROS production, redox stress, and a cycle of senescence, cytokine production, and impaired oxidative phosphorylation. Targeting the formation or accumulation of oxidized biomolecules, particularly oxidized lipids, in immune cells and mitochondria could be beneficial for age-related inflammation and comorbidities. Recent Advances: Inflammation is central to age-related decline in health and exhibits a complex relationship with mitochondrial redox state and metabolic function. Improvements in mass spectrometric methods have led to the identification of families of oxidized phospholipids (OxPLs), cholesterols, and fatty acids that increase during inflammation and which modulate nuclear factor erythroid 2-related factor 2 (Nrf2), peroxisome proliferator-activated receptor gamma (PPARγ), activator protein 1 (AP1), and NF-κB redox-sensitive transcription factor activity. Critical Issues: The kinetic and spatial resolution of the modified lipidome has profound and sometimes opposing effects on inflammation, promoting initiation at high concentration and resolution at low concentration of OxPLs. Future Directions: There is an emerging opportunity to prevent or delay age-related inflammation and vascular comorbidity through a resolving (oxy)lipidome that is dependent on improving mitochondrial quality control and restoring redox homeostasis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lie完成签到,获得积分10
刚刚
Elena完成签到,获得积分10
2秒前
3秒前
JamesPei应助嘻嘻采纳,获得10
4秒前
zzx发布了新的文献求助20
4秒前
5秒前
5秒前
WYMD应助CGDAZE采纳,获得40
6秒前
大鱼大鱼完成签到,获得积分10
6秒前
6秒前
JamesPei应助呜呜采纳,获得10
6秒前
8秒前
Rayson完成签到,获得积分10
10秒前
脑洞疼应助勤恳的向日葵采纳,获得10
10秒前
约以文发布了新的文献求助20
10秒前
11秒前
11秒前
Wakey完成签到,获得积分10
11秒前
11秒前
共享精神应助天真念烟采纳,获得10
11秒前
11秒前
Lollipopzz发布了新的文献求助20
12秒前
梨勿发布了新的文献求助10
12秒前
灰色发布了新的文献求助10
13秒前
15秒前
yck1027完成签到,获得积分10
16秒前
16秒前
EIO团队完成签到 ,获得积分10
17秒前
zz完成签到 ,获得积分10
17秒前
赘婿应助青云之志采纳,获得10
18秒前
cy完成签到,获得积分20
19秒前
科研通AI6.2应助cyn采纳,获得10
21秒前
受伤的行云完成签到,获得积分10
21秒前
无花果应助随风守着她采纳,获得10
21秒前
犹豫的烨霖完成签到,获得积分10
22秒前
23秒前
你们都是好人呀完成签到,获得积分10
24秒前
sylviecssw发布了新的文献求助20
28秒前
星辰大海应助wen采纳,获得10
29秒前
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6955391
求助须知:如何正确求助?哪些是违规求助? 8638983
关于积分的说明 18319826
捐赠科研通 6400425
什么是DOI,文献DOI怎么找? 3083587
关于科研通互助平台的介绍 2130094
邀请新用户注册赠送积分活动 2060416